Penny Stock Insider Trading
Tracking Executive Conviction in Stocks Under $5
Insider Activity in Low-Priced Equities
Insider trading in penny stocks often carries significant weight due to the high volatility inherent in smaller companies. When a director or CEO of a low-cap firm purchases shares, it can signal a major belief in an upcoming fundamental shift.
| Filing Date | Trade Date | Ticker | Company Name | Reporting Person | Relationship | Industry | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-02-11 00:22 | 2026-02-06 | MNTR | Mentor Capital, Inc. | Billingsley Chester | Director, Officer, 10% owner - Chief Executive Officer | Investors, NEC | BUY | $0.09 | 1,998 | $179 | 3,174,296 | +0.1% |
| 2026-02-11 02:58 | 2026-02-09 | RPID | RAPID MICRO BIOSYSTEMS, INC. | Wilson John J. Addington | Officer - CHIEF OPERATING OFFICER | Laboratory Analytical Instruments | SELL | $3.78 | 4,610 | -$17,438 | 257,768 | -1.8% |
| 2026-02-11 02:52 | 2026-02-09 | RPID | RAPID MICRO BIOSYSTEMS, INC. | Spignesi Robert G. Jr. | Director, Officer - PRESIDENT AND CEO | Laboratory Analytical Instruments | SELL | $3.78 | 12,840 | -$48,570 | 962,097 | -1.3% |
| 2026-02-11 02:54 | 2026-02-09 | RPID | RAPID MICRO BIOSYSTEMS, INC. | WIRTJES SEAN M | Officer - CHIEF FINANCIAL OFFICER | Laboratory Analytical Instruments | SELL | $3.78 | 6,027 | -$22,798 | 483,928 | -1.2% |
| 2026-02-11 00:35 | 2026-02-06 | EU | enCore Energy Corp. | SHERIFF WILLIAM M | Director, Officer - See Remarks | Miscellaneous Metal Ores | SELL | $2.76 | 24,000 | -$66,240 | 2,214,055 | -1.1% |
| 2026-02-11 00:25 | 2026-02-09 | LSAK | LESAKA TECHNOLOGIES INC | Mazanderani Ali | Director, Officer - Executive Chairman | Functions Related To Depository Banking, NEC | BUY | $4.36 | 91,423 | $398,604 | 2,416,538 | +3.9% |
| 2026-02-11 05:09 | 2026-02-06 | ZNTL | Zentalis Pharmaceuticals, Inc. | EASTLAND JULIA MARIE | Director, Officer - CEO & President | Pharmaceutical Preparations | SELL | $2.43 | 8,755 | -$21,240 | 79,133 | -10.0% |
| 2026-02-11 05:10 | 2026-02-06 | ZNTL | Zentalis Pharmaceuticals, Inc. | Vultaggio Vincent | Officer - PAO and PFO | Pharmaceutical Preparations | SELL | $2.43 | 40,224 | -$97,555 | 146,506 | -21.5% |
| 2026-02-11 05:10 | 2026-02-06 | ZNTL | Zentalis Pharmaceuticals, Inc. | Bruns Ingmar | Officer - Chief Medical Officer | Pharmaceutical Preparations | SELL | $2.43 | 3,297 | -$7,999 | 33,332 | -9.0% |
| 2026-02-10 23:19 | 2026-02-10 | IRIX | IRIDEX CORP | Dizon Romeo R | Officer - Chief Financial Officer | Electromedical & Electrotherapeutic Apparatus | BUY | $1.46 | 1,000 | $1,460 | 116,190 | +0.9% |
| 2026-02-10 22:05 | 2026-02-02 | TPET | Trio Petroleum Corp | Randall John W. | Director | Crude Petroleum & Natural Gas | SELL | $0.64 | 20,000 | -$12,782 | 155,500 | -11.4% |
| 2026-02-10 22:27 | 2025-12-18 | RCG | RENN Fund, Inc. | DOYLE PETER | Other | Other | BUY | $2.60 | 300 | $780 | 300 | +100.0% |
| 2026-02-10 18:25 | 2026-02-09 | RCG | RENN Fund, Inc. | STAHL MURRAY | Officer, 10% owner - President/Co-Portfolio Manager | Other | BUY | $2.68 | 1,134 | $3,039 | 65,400 | +1.8% |
| 2026-02-10 00:06 | 2026-02-05 | ZIP | ZIPRECRUITER, INC. | YARBROUGH TIMOTHY G. | Officer - EVP, Chief Financial Officer | Services-Computer Programming, Data Processing, Etc. | SELL | $1.97 | 3,034 | -$5,981 | 66,345 | -4.4% |
| 2026-02-10 00:10 | 2026-02-06 | COCP | Cocrystal Pharma, Inc. | FROST PHILLIP MD ET AL | Director, 10% owner | Pharmaceutical Preparations | BUY | $0.95 | 50,000 | $47,280 | 1,888,551 | +2.7% |
| 2026-02-10 00:07 | 2026-02-06 | CDXS | CODEXIS, INC. | Lutz Stefan | Officer - Chief Scientific Officer | Industrial Organic Chemicals | SELL | $1.31 | 2,492 | -$3,257 | 136,283 | -1.8% |
| 2026-02-10 00:07 | 2026-02-06 | CDXS | CODEXIS, INC. | Erbez Georgia | Officer - See Remarks | Industrial Organic Chemicals | SELL | $1.31 | 3,826 | -$5,001 | 66,810 | -5.4% |
| 2026-02-10 00:06 | 2026-02-06 | CDXS | CODEXIS, INC. | MOORE ALISON | Director, Officer - President and CEO | Industrial Organic Chemicals | SELL | $1.31 | 3,826 | -$5,001 | 250,506 | -1.5% |
| 2026-02-10 00:25 | 2026-02-06 | GALT | GALECTIN THERAPEUTICS INC | ELDRED KARY | Director | Pharmaceutical Preparations | BUY | $2.70 | 300 | $810 | 65,682 | +0.5% |
| 2026-02-10 05:09 | 2026-02-06 | SPRO | Spero Therapeutics, Inc. | Keutzer Timothy | Officer - Chief Operating Officer | Pharmaceutical Preparations | SELL | $2.36 | 18,652 | -$44,019 | 742,506 | -2.5% |
| 2026-02-10 05:31 | 2026-02-06 | SPRO | Spero Therapeutics, Inc. | Rajavelu Esther | Officer - See Remarks | Pharmaceutical Preparations | SELL | $2.36 | 87,917 | -$207,484 | 1,012,091 | -8.0% |
| 2026-02-10 00:39 | 2026-02-05 | UWMC | UWM Holdings Corp | Mat Ishbia | Director, Officer, 10% owner - President and CEO | Mortgage Bankers & Loan Correspondents | SELL | $4.85 | 1,898,622 | -$9,208,317 | 3,692,273 | -34.0% |
| 2026-02-09 23:23 | 2026-02-04 | STQN | STRATEGIC ACQUISITIONS INC /NV/ | OSHEA JOHN P | Director, Officer, 10% owner - President | Finance Services | BUY | $0.00 | 30,000,000 | $30,000 | 30,151,800 | +19,762.8% |
| 2026-02-09 19:36 | 2026-02-06 | RCG | RENN Fund, Inc. | STAHL MURRAY | Officer, 10% owner - President/Co-Portfolio Manager | Other | BUY | $2.70 | 1,134 | $3,062 | 65,318 | +1.8% |
| 2026-02-07 00:30 | 2026-02-04 | TSHA | Taysha Gene Therapies, Inc. | Alam Kamran | Officer - CHIEF FINANCIAL OFFICER | Biological Products, (No Diagnostic Substances) | SELL | $4.52 | 1,655 | -$7,481 | 1,442,131 | -0.1% |
| 2026-02-07 01:53 | 2026-02-04 | RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Director | Biological Products, (No Diagnostic Substances) | SELL | $4.12 | 40,000 | -$164,800 | 913,839 | -4.2% |
| 2026-02-07 01:53 | 2026-02-03 | RXRX | RECURSION PHARMACEUTICALS, INC. | Borgeson Blake | Director | Biological Products, (No Diagnostic Substances) | SELL | $4.20 | 220,000 | -$924,000 | 6,429,863 | -3.3% |
| 2026-02-07 00:37 | 2025-07-03 | CV | CapsoVision, Inc | Tsai Chen Lung | Director | Electromedical & Electrotherapeutic Apparatus | BUY | $4.17 | 20 | $83 | 20 | +100.0% |
| 2026-02-07 01:40 | 2026-02-04 | SNES | SenesTech, Inc. | GLENBROOK CAPITAL MANAGEMENT | 10% owner | Agricultural Chemicals | BUY | $1.81 | 8,569 | $15,480 | 602,354 | +1.4% |
| 2026-02-07 00:26 | 2026-02-04 | RPID | RAPID MICRO BIOSYSTEMS, INC. | Longitude Capital Partners II, LLC | 10% owner | Laboratory Analytical Instruments | SELL | $3.88 | 49,000 | -$190,091 | 0 | -100.0% |
| 2026-02-06 19:31 | 2026-02-05 | RCG | RENN Fund, Inc. | STAHL MURRAY | Officer, 10% owner - President/Co-Portfolio Manager | Other | BUY | $2.64 | 1,134 | $2,994 | 65,236 | +1.8% |
| 2026-02-07 00:12 | 2026-02-04 | STQN | STRATEGIC ACQUISITIONS INC /NV/ | OSHEA JOHN P | Director, Officer - President | Finance Services | SELL | $0.00 | 30,000,000 | -$30,000 | 30,151,800 | -49.9% |
| 2026-02-06 02:46 | 2026-02-04 | IRAB | Iris Acquisition Corp II | Iris Acquisition Holdings II LLC | 10% owner | Blank Checks | BUY | $0.00 | 251,000 | $0 | 251,000 | +100.0% |
| 2026-02-06 02:20 | 2025-12-18 | CFND | C1 Fund Inc. | Singer Jeffrey H. | Director | Other | BUY | $4.89 | 2,000 | $9,780 | 2,000 | +100.0% |
| 2026-02-06 00:14 | 2026-02-03 | IPSC | Century Therapeutics, Inc. | Carr Douglas | Officer - SVP Finance & Operations | Biological Products, (No Diagnostic Substances) | SELL | $1.82 | 323 | -$589 | 514,551 | -0.1% |
| 2026-02-06 02:47 | 2026-02-04 | IRAB | Iris Acquisition Corp II | Mehta Sumit | Officer - Chief Executive Officer | Blank Checks | BUY | $0.00 | 251,000 | $0 | 251,000 | +100.0% |
| 2026-02-06 02:48 | 2026-02-04 | IRAB | Iris Acquisition Corp II | Nanani Rohit | Director | Blank Checks | BUY | $0.00 | 251,000 | $0 | 251,000 | +100.0% |
| 2026-02-05 18:18 | 2026-02-03 | CLNN | Clene Inc. | Ugwumba Chidozie | 10% owner | Pharmaceutical Preparations | SELL | $4.10 | 5,559 | -$22,792 | 550,000 | -1.0% |
| 2026-02-06 00:26 | 2026-02-03 | CSAI | CLOUDASTRUCTURE, INC. | Bentley Sheldon Richard | 10% owner, Other | Services-Computer Programming, Data Processing, Etc. | SELL | $0.58 | 50,000 | -$29,000 | 50,000 | -50.0% |
| 2026-02-05 14:30 | 2026-02-02 | SPRO | Spero Therapeutics, Inc. | Keutzer Timothy | Officer - Chief Operating Officer | Pharmaceutical Preparations | SELL | $2.17 | 46,586 | -$101,175 | 761,158 | -5.8% |
| 2026-02-06 03:19 | 2026-02-03 | ZIP | ZIPRECRUITER, INC. | SIEGEL IAN H. | Director, Officer, 10% owner - CHIEF EXECUTIVE OFFICER | Services-Computer Programming, Data Processing, Etc. | SELL | $2.11 | 29,166 | -$61,464 | 33,618 | -46.5% |
| 2026-02-06 00:17 | 2026-02-03 | MNTR | Mentor Capital, Inc. | Billingsley Chester | Director, Officer, 10% owner - Chief Executive Officer | Investors, NEC | BUY | $0.09 | 3,002 | $265 | 3,172,298 | +0.1% |
| 2026-02-06 01:12 | 2026-02-03 | KOS | Kosmos Energy Ltd. | Marion Josh R. | Officer - SVP and General Counsel | Crude Petroleum & Natural Gas | SELL | $1.38 | 22,940 | -$31,593 | 194,125 | -10.6% |
| 2026-02-06 01:12 | 2026-02-03 | KOS | Kosmos Energy Ltd. | Shah Nealesh D. | Officer - SVP and CFO | Crude Petroleum & Natural Gas | SELL | $1.39 | 79,124 | -$109,634 | 1,705,167 | -4.4% |
| 2026-02-06 01:13 | 2026-02-03 | KOS | Kosmos Energy Ltd. | Glass Ronald W. | Officer - VP & Chief Accounting Officer | Crude Petroleum & Natural Gas | SELL | $1.38 | 22,598 | -$31,124 | 339,632 | -6.2% |
| 2026-02-06 01:10 | 2026-02-03 | KOS | Kosmos Energy Ltd. | INGLIS ANDREW G | Director, Officer - Chairman and CEO | Crude Petroleum & Natural Gas | SELL | $1.39 | 148,182 | -$205,247 | 4,227,017 | -3.4% |
| 2026-02-05 21:05 | 2026-02-04 | RCG | RENN Fund, Inc. | STAHL MURRAY | Officer, 10% owner - President/Co-Portfolio Manager | Other | BUY | $2.73 | 1,134 | $3,096 | 65,154 | +1.8% |
| 2026-02-05 05:21 | 2026-02-02 | NBRG | Newbridge Acquisition Ltd | Wealth Path Holdings Ltd | 10% owner | Blank Checks | BUY | $0.00 | 186,250 | $0 | 186,250 | +100.0% |
| 2026-02-05 00:30 | 2026-02-02 | FEAM | 5E Advanced Materials, Inc. | BEP Special Situations IV LLC | Director, 10% owner | Mining & Quarrying of Nonmetallic Minerals (No Fuels) | BUY | $2.00 | 4,000,000 | $8,000,000 | 12,130,997 | +49.2% |
| 2026-02-05 00:53 | 2026-02-02 | MOBX | MOBIX LABS, INC | SANSONE PHILIP | Director, Officer - Chief Executive Officer | Semiconductors & Related Devices | SELL | $0.19 | 87,025 | -$16,361 | 1,848,816 | -4.5% |
High Risk, High Reward Insider Trades
Penny stocks are notoriously volatile, but when insiders put their own money into stocks priced under $5, it provides a unique layer of validation. Unlike large-cap stocks where buys might be routine, a million-share purchase at $0.50 can indicate that management sees a path to recovery or exponential growth. Our tracking allows you to identify ini speculative signals in real-time, focusing on the capital flow of those with intimate industry knowledge. Following these low-cap moves helps bridge the information gap in the most volatile market segments.
Identifying Legitimate Micro-Cap Conviction
Our Penny Stock Filter isolates the most speculative yet promising filings from the SEC Form 4 feed. By focusing on low-priced equities, we highlight where CEOs and Directors are taking meaningful positions. This list is essential for small-cap investors looking to follow the capital of those with intimate knowledge of a company's research, patents, or upcoming regulatory approvals. Eliminate the noise and focus strictly on high-impact accumulation from leadership betting big on their company’s future value in the micro-cap space.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.